In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.

Abroad (travel likely)RecruitingPHASE3

Conditions

Apathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Bordeaux University Hospital, Bordeaux, France
Contact: Study coordinator (Nicolas BALAMOUTOFF) · nicolas.balamoutoff@chu-bordeaux.fr · 05 56 79 55 40
Contact: Study coordinator (Joachim MAZERE) · joachim.mazere@chu-bordeaux.fr · 05 57 65 64 08

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Apathy · Schizophrenia · Schizophrenia; Psychosis

Abroad (travel likely)RecruitingPHASE3

Shreveport, United States

Accelerated rTMS vs. Sham for Stroke Apathy

Apathy · Stroke · Stroke Sequelae

Abroad (travel likely)RecruitingPHASE1, PHASE2

Charleston, United States

Robotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel)

Apathy · Apathy in Dementia

Abroad (travel likely)Recruiting

Milan, Italy · Modena, Italy

rTMS for Apathy Clinical Trial

Alzheimer Disease · Apathy in Dementia · Dementia

Abroad (travel likely)Recruiting

Toronto, Canada